Table 1.
Patient demographics and NSCLC tumor characteristics.
| Characteristics | Number of patients (%) | ||
|---|---|---|---|
| Age | 68 (50, 84)a | ||
| Gender | Male | 23 (67.6%) | |
| Female | 11 (32.4%) | ||
| Histology | Adenocarcinoma | 6 (17.6%) | |
| Squamous cell carcinoma | 12 (35.3%) | ||
| NSCLC-NOS | 16 (47.1%) | ||
| Concurrent chemotherapy | Yes | 21 (61.8%) | |
| No | 13 (38.2%) | ||
| Physical RT dose (Gy) | 66 (45.0, 85.5)a | ||
| Inter-scan interval (day) | 43 (11, 281)a | ||
| Time to treatment (day) | 48 (18, 293)a | ||
| First scan | Second scan | ||
| Overall stage | I | 6 (17.6%) | 5 (14.7%) |
| II | 5 (14.7%) | 5 (14.7%) | |
| III | 23 (67.6%) | 22 (64.7%) | |
| IV | 0 | 2 (5.9%) | |
| T stage | Tx | 2 (5.9%) | 2 (5.9%) |
| T1 | 9 (26.5%) | 9 (26.5%) | |
| T2 | 5 (14.7%) | 5 (14.7%) | |
| T3 | 10 (29.4%) | 9 (26.5%) | |
| T4 | 8 (23.5%) | 9 (26.5%) | |
| N stage | N0 | 10 (29.4%) | 9 (26.5%) |
| N1 | 3 (8.8%) | 3 (8.8%) | |
| N2 | 14 (41.2%) | 14 (41.2%) | |
| N3 | 7 (20.6%) | 8(23.5%) |
NSCLC-NOS, non-small cell lung cancer – not otherwise speci.ed; RT, radiation therapy
a
Presented as median (range).